Brief: ReShape Lifesciences Reports Year Ended 2021 Financial And Operating Results
March 28 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES™ REPORTS YEAR ENDED 2021 FINANCIAL
AND
OPERATING RESULTS AND PROVIDES CORPORATE UPDATE
* RESHAPE LIFESCIENCES INC - CASH AND CASH EQUIVALENTS WERE
$22.8
MILLION AS OF DECEMBER 31, 2021
* RESHAPE LIFESCIENCES INC - REVENUE FOR YEAR ENDED DECEMBER
31,
2021, WAS $13.6 MILLION COMPARED TO $11.3 MILLION FOR YEAR ENDED
DECEMBER 31, 2020
Source text for Eikon: ID:nGNX1lHkT7
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity